Deere & Company’s Edwards Lifesciences EW Stock Holding History

Deere & Company’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-65,742	Closed	-$2.64M	–	249
2016 Q3	$2.64M	Sell	65,742 -615	-0.9%	-$23.2K	0.14%	144
2016 Q2	$2.21M	Buy	66,357 +36,327	+121%	+$1.24M	0.12%	162
2016 Q1	$883K	Sell	30,030 -36,018	-55%	-$994K	0.05%	416
2015 Q4	$1.74M	Sell	66,048 -108	-0.2%	-$2.81K	0.1%	227
2015 Q3	$1.57M	Sell	66,156 -12,414	-16%	-$300K	0.1%	256
2015 Q2	$1.86M	Buy	78,570 +2,754	+4%	+$62.1K	0.1%	218
2015 Q1	$1.8M	Buy	75,816 +852	+1%	+$19.1K	0.1%	261
2014 Q4	$1.59M	Sell	74,964 -9,150	-11%	-$184K	0.09%	275
2014 Q3	$1.43M	Sell	84,114 -25,974	-24%	-$410K	0.08%	254
2014 Q2	$1.57M	Buy	+110,088	New	+$1.49M	0.09%	260

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Deere & Company's EW Position: Q4 2016 in Review

Deere & Company sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 65,742 shares — an estimated $2.64M sold.

Deere & Company first reported a position in EW in Q2 2014 and held it in 10 quarters. The position peaked at $2.64M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

Deere & Company reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
Deere & Company sold 65,742 Edwards Lifesciences shares in Q4 2016, an estimated $2.64M.
Deere & Company first reported a position in Edwards Lifesciences in Q2 2014 and held it in 10 quarters.
Deere & Company's Edwards Lifesciences position peaked at $2.64M in Q3 2016.
686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on Deere & Company's 13F filing for Q4 2016, filed 13 Feb 2017.